Holmes KT - Search Results

1

Washout periods for brimonidine 0.2% and latanoprost 0.005%.

Stewart WC, Holmes KT, Johnson MA. Stewart WC, et al. Among authors: holmes kt. Am J Ophthalmol. 2001 Jun;131(6):798-9. doi: 10.1016/s0002-9394(00)00930-2. Am J Ophthalmol. 2001. PMID: 11384581

2

Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost.

Stewart WC, Day DG, Sharpe ED, Dubiner HB, Holmes KT, Stewart JA. Stewart WC, et al. Among authors: holmes kt. Am J Ophthalmol. 1999 Dec;128(6):692-6. doi: 10.1016/s0002-9394(99)00237-8. Am J Ophthalmol. 1999. PMID: 10612504 Clinical Trial.

3

Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.

Stewart WC, Sharpe ED, Day DG, Kolker AE, Konstas AG, Lee WH, Rieser JC, Chopra H, Holmes KT. Stewart WC, et al. Among authors: holmes kt. J Ocul Pharmacol Ther. 2000 Jun;16(3):251-9. doi: 10.1089/jop.2000.16.251. J Ocul Pharmacol Ther. 2000. PMID: 10872922

4

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure.

Stewart WC, Sharpe ED, Harbin TS Jr, Pastor SA, Day DG, Holmes KT, Stewart JA. Stewart WC, et al. Among authors: holmes kt. Am J Ophthalmol. 2000 Jun;129(6):723-7. doi: 10.1016/s0002-9394(00)00381-0. Am J Ophthalmol. 2000. PMID: 10926979 Clinical Trial.

5

Factors associated with long-term progression or stability in primary open-angle glaucoma.

Stewart WC, Kolker AE, Sharpe ED, Day DG, Holmes KT, Leech JN, Johnson M, Cantrell JB. Stewart WC, et al. Among authors: holmes kt. Am J Ophthalmol. 2000 Sep;130(3):274-9. doi: 10.1016/s0002-9394(00)00487-6. Am J Ophthalmol. 2000. PMID: 11020404 Clinical Trial.

6

Differences in ocular surface irritation between timolol hemihydrate and timolol maleate.

Stewart WC, Stewart JA, Holmes KT, Leech JN. Stewart WC, et al. Among authors: holmes kt. Am J Ophthalmol. 2000 Dec;130(6):712-6. doi: 10.1016/s0002-9394(00)00611-5. Am J Ophthalmol. 2000. PMID: 11124288 Clinical Trial.

7

Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.

Stewart WC, Day DG, Stewart JA, Holmes KT, Leech JN, Rowan CT, Schwartz GF. Stewart WC, et al. Among authors: holmes kt. J Ocul Pharmacol Ther. 2000 Dec;16(6):557-64. doi: 10.1089/jop.2000.16.557. J Ocul Pharmacol Ther. 2000. PMID: 11132902 Clinical Trial.

8

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.

Stewart WC, Sharpe ED, Stewart JA, Holmes KT, Latham KE. Stewart WC, et al. Among authors: holmes kt. Am J Ophthalmol. 2001 Mar;131(3):339-44. doi: 10.1016/s0002-9394(00)00824-2. Am J Ophthalmol. 2001. PMID: 11239866 Clinical Trial.

9

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.

Konstas AG, Stewart WC, Topouzis F, Tersis I, Holmes KT, Stangos NT. Konstas AG, et al. Among authors: holmes kt. Am J Ophthalmol. 2001 Jun;131(6):729-33. doi: 10.1016/s0002-9394(01)00834-0. Am J Ophthalmol. 2001. PMID: 11384568 Clinical Trial.

10

Effect of timolol 0.5% gel and solution on pulmonary function in older glaucoma patients.

Stewart WC, Day DG, Holmes KT, Stewart JA. Stewart WC, et al. Among authors: holmes kt. J Glaucoma. 2001 Jun;10(3):227-32. doi: 10.1097/00061198-200106000-00015. J Glaucoma. 2001. PMID: 11442188 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page